FIELD: medicine; clinical oncology; medical genetics; molecular diagnostics.
SUBSTANCE: invention can be used to predict a low risk of developing breast cancer in Russian women with highly penetrating mutations in the BRCA1 and CHEK2 genes. DNA from the peripheral venous blood is isolated. The BRCA1 and CHEK2 genes are analyzed, namely the BRCAlinsC5382, BRCA1 185delAG, BRCA1 2080delA, CHEK2 I157T polymorphisms, and the rs1940475 polymorphism of MMP8 gene. A protective factor in the development of breast cancer in women with highly penetrate mutations in the BRCA1 and CHEK2 genes, namely in the polymorphic loci BRCAlinsC5382, BRCA1 185delAG, BRCA1 2080delA, CHEK2 I157T, is TT genotype of rs1940475 polymorphism of MMP8 gene.
EFFECT: method provides for obtaining new criteria for assessing the low risk of developing breast cancer in Russian women, natives of the Central Black Earth region of the Russian Federation with highly penetrating mutations in the BRCA1 and CHEK2 genes, namely in the polymorphic loci BRCAlinsC5382, BRCA1 185delAG, BRCA1 2080delA, CHEK2 I157T, based on data on the rs1940475 polymorphism of MMP8 gene.
1 cl, 5 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
DETERMINATION OF CANCER SUSCEPTIBILITY BY IDENTIFICATION OF GENOTYPIC COMBINATIONS OF SPECIFIC VERSIONS OF CYP1B1, BRCA2 AND CHEK2 GENES | 2006 |
|
RU2470998C2 |
METHOD FOR IDENTIFYING RECESSIVE FACTORS OF GENETIC PREDISPOSITION TO BREAST CANCER | 2013 |
|
RU2535157C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN BASED ON DATA ON INTERLOCUS INTERACTIONS | 2023 |
|
RU2815932C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING BREAST CANCER IN WOMEN USING MOLECULAR GENETIC DATA | 2022 |
|
RU2795897C1 |
METHOD FOR PREDICTION OF INCREASED RICK OF DEVELOPING STAGE 1-2 BREAST CANCER IN WOMEN BASED ON POLYMORPHISM OF THE MATRIX METALLOPROTEINASE 9 GENE | 2022 |
|
RU2795100C1 |
METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN NON-OBESE WOMEN | 2023 |
|
RU2795726C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF THE LUMINAL SUBTYPE OF BREAST CANCER | 2023 |
|
RU2795720C1 |
METHOD OF PREDICTING RISK OF DEVELOPING TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2811257C1 |
METHOD FOR PREDICTING RISK OF GRADE 3 MALIGNANCY OF TUMOR CELLS IN BREAST CANCER | 2023 |
|
RU2823459C1 |
METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN OBESE WOMEN | 2022 |
|
RU2795244C1 |
Authors
Dates
2023-06-23—Published
2022-11-03—Filed